LENSAR is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining better visual outcomes, efficiency and reproducibility by providing advanced imaging, simplified procedure planning, efficient design and precision.

$7.00  +0.20 (2.94%)
As of 12/03/2021 16:00:01 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  USA
IPO date:  10/02/2020
Outstanding shares:  10,956,688
Average volume:  7,869
Market cap:   $74,505,478
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    52634L108
ISIN:        US52634L1089
Valuation   (See tab for details)
PE ratio:   -3.40
PB ratio:   1.34
PS ratio:   2.36
Return on equity:   -39.49%
Net income %:   -71.47%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy